v1
Adjuvant oral razoxane (ICRF-159) in resectable colorectal cancer.
Identifier:nobleid.org/w1/20260515/C55FDF7E
Type:Journal Article
0 views
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →